How Much Did CVasThera Raise?
Funding & Key Investors

CVasThera has secured $1.6M in total funding, with its most recent capital infusion of $1.6M described as a major strategic investment. This significant backing underscores the company's progress in the biopharmaceutical sector and its potential for future growth and innovation in drug discovery and development.

What is CVasThera?

CVasThera
ManufacturingPharmaceuticalsBusiness Services

CVasThera is a biopharmaceutical company established in 2016 by seasoned professionals with deep expertise in drug discovery and development. The company's core mission is to reimagine and advance innovative molecules to enhance patient lives. CVasThera offers specialized capabilities in clinical trials and drug optimization, operating on a business model that prioritizes access to scientific acumen, strategic funding, accelerated timelines to clinical proof of concept, and robust intellectual property strategies. By forging collaborations with global partners, CVasThera aims to generate substantial value and drive progress in healthcare solutions.

How much funding has CVasThera raised?

CVasThera has raised a total of $1.6M across 1 funding round:

2021

Other Financing Round

$1.6M

Other Financing Round (2021): $1.6M with participation from OCSEED, Agence nationale de la recherche ANR, and Bpifrance

Key Investors in CVasThera

OCSEED

OCSEED is an entity that has participated in the funding round for CVasThera, contributing to the company's overall capital.

Agence nationale de la recherche ANR

The Agence nationale de la recherche (ANR) is a French public agency that finances research projects, supporting CVasThera's innovative endeavors in drug discovery and development.

Bpifrance

Bpifrance is a French public investment bank that finances companies at every stage of their development, providing credit, guarantees, and equity, and supporting innovation and international expansion.

What's next for CVasThera?

With the recent major strategic investment, CVasThera is poised to accelerate its development pipeline and expand its research initiatives. The substantial enterprise-level funding suggests a focus on scaling operations, advancing key drug candidates through clinical stages, and potentially broadening its global partnerships. This capital infusion will likely empower CVasThera to further solidify its position in the competitive biopharmaceutical landscape and pursue its objective of delivering novel healthcare solutions.

See full CVasThera company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Hand, Power & Lawn-care ToolsManufacturingIndustrial Machinery & Equipment
Industrial Machinery & EquipmentManufacturingOther Rental Stores (Furniture, A/V, Construction & Industrial Equipment)Retail
Industrial Machinery & EquipmentManufacturingArchitecture, Engineering & DesignConstruction
ManufacturingPlastic, Packaging & Containers

Frequently Asked Questions Regarding CVasThera Financial Insights

What are the most recent funding rounds that CVasThera has completed, and what were the funding rounds?
CVasThera has recently completed 1 funding rounds: Other Financing Round on Mar 3, 2021.
What is the total amount of funding CVasThera has raised to date?
CVasThera has raised a total of $1.6M in funding to date.
How many funding rounds has CVasThera completed?
CVasThera has completed 1 funding rounds.
How much funding did CVasThera raise in its most recent funding round?
CVasThera raised $1.6M in its most recent funding round.
Who are the lead investors in CVasThera's latest funding round?
The lead investor in CVasThera's latest funding round was OCSEED. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in CVasThera's history?
The largest funding round in CVasThera's history was $1.6M.
See more information about CVasThera